Healthcare commercialisation group NetScientific announced on Monday that its portfolio company Wanda has achieved highly positive results in a study with congestive heart failure patients. The study involved a system developed by Wanda which continuously assesses patients in real time and can detect adverse events up to a week before they happen, and resulted in a 46% reduction in hospital readmission rates for patients suffering from the heart condition. AIM-traded company NetScientific holds ...Den vollständigen Artikel lesen ...